Navigation Links
Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2013
Date:7/25/2013

al Status 19

Clinical Trials by E7 Nations 21

Clinical Trials in E7 Nations by Trial Status 22

Clinical Trials by Phase 23

In Progress Trials by Phase 24

Clinical Trials by Trial Status 25

Unaccomplished Trials of Peripheral Neuropathy (Sensory Neuropathy) 26

Subjects Recruited Over a Period of Time 30

Prominent Sponsors 31

Top Companies Participating in Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials 33

Prominent Drug Comparison 35

Clinical Trial Profiles 36

Clinical Trial Overview of Top Companies 36

Pfizer Inc. 36

Clinical Trial Overview of Pfizer Inc. 36

NeurogesX, Inc. 37

Clinical Trial Overview of NeurogesX, Inc. 37

GW Pharmaceuticals plc 38

Clinical Trial Overview of GW Pharmaceuticals plc 38

Johnson & Johnson 39

Clinical Trial Overview of Johnson & Johnson 39

CSL Behring LLC 40

Clinical Trial Overview of CSL Behring LLC 40

Origin BioMed, Inc. 41

Clinical Trial Overview of Origin BioMed, Inc. 41

Endo Pharmaceuticals Inc. 42

Clinical Trial Overview of Endo Pharmaceuticals Inc. 42

Protemix Corporation Limited 43

Clinical Trial Overview of Protemix Corporation Limited 43

Neurotune AG 44

Clinical Trial Overview of Neurotune AG 44

Eisai Inc. 45

Clinical Trial Overview of Eisai Inc. 45

Lupin Limited 46

Clinical Trial Overview of Lupin Limited 46

Merck KGaA 47

Clinical Trial Overview of Merck KGaA 47

Sigma-Tau S.p.A. 48

Clinical Trial Overview of Sigma-Tau S.p.A. 48

Bristol-Myers Squibb Company 49

Clinical Trial Overview of Bristol-Myers Squibb Company 49

Octapharma AG 50

Clinical Trial Overview of Octapharma AG 50

Laboratorios Del Dr. Esteve S.A. 51

Clinical Trial Overview of Laboratorios Del Dr. Esteve S.A. 51

Cubist Pharma
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Synthetically Optimized HIF-1 Alpha DNA Delivered with Inovios Electroporation Technology Provides Significant Therapeutic Effects for Peripheral Arterial Disease in Animal Model
2. Peripheral Vascular Devices Market (Peripheral Vascular Stents, PTA Balloon Catheters, Guidewires, IVC Filters, Atherectomy, Chronic Total Occlusion, Embolic Protection Devices, Synthetic Surgical Grafts, Aortic Stents) - Global Industry Analysis, S
3. QualiMed Innovative Medizinprodukte GmbH, Based in Winsen Germany has Received Notice of CE Approval for its Line of Peripheral Balloons for the Treatment of Peripheral Vascular Obstructions
4. US Peripheral Vascular Device Market to Grow Strongly to $3.3 Billion by 2017
5. Peripheral Vascular Devices Market to 2018 - Increasing Demand for Minimally Invasive Endovascular Procedures Presents Growth Opportunities for Manufacturers
6. Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Chemotherapy-Induced Peripheral Neuropathy
7. Anesthesia Equipment and Associated Peripherals: Advanced, Patient-Friendly Devices Will Sustain Market Growth in Europe, States Frost & Sullivan
8. Peripheral Vascular Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
9. Global Peripheral Vascular Devices Market 2011-2015
10. Brazil Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others
11. North America Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology Prosthetic Heart Valves and Others
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 As health officials across ... virus, select Meijer pharmacies in Michigan ... to eligible patients, enabling Meijer pharmacists to administer tests and, ... set by a physician participating in the study. ...
(Date:1/15/2014)... Calif. , Jan. 15, 2014 Massachusetts ... (NASDAQ: AMGN ) announced today that ... discover and validate new therapeutic targets and develop ... chronic disorder that affects millions worldwide. The MGH-Broad-Amgen ...
(Date:1/15/2014)...  Manufacturers, suppliers and distributors of innovative medical-related products ... most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the Medical ... most litigious industry sectors of cases involving IP ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Intellectual Property Insurance for Medical-related Products and Services 2
... George Products Company, Inc. has announced the addition ... OASIS Inspection Systems. Florida Metrology, based ... OASIS Inspection Systems is a line of highly accurate ... control departments across the United States. Tim Row of ...
... Sutro Biopharma, a biopharmaceutical company developing both ... properties, today announced that it has appointed Trevor ... Hallam will lead Sutro,s ongoing efforts in the ... platform for the research and development of novel ...
Cached Medicine Technology:Florida Metrology To Distribute OASIS Inspection Systems 2Sutro Biopharma Appoints Trevor Hallam, Ph.D., as Chief Scientific Officer 2
(Date:4/18/2014)... release is available in French . ... revolutionize surgical practice and regenerative medicine. A team led ... Chimie (CNRS/ESPCI Paris Tech) and Didier Letourneur from the ... 13), has just demonstrated that the principle of adhesion ... vivo to repair soft-tissue organs and tissues. This easy-to-use ...
(Date:4/17/2014)... first genetic variant specifically associated with the risk ... 10-15 per cent of all breast cancer cases. ... cancer sub-type, called invasive lobular carcinoma, gives researchers ... particular kind of breast cancer, which can be ... (Thursday) in the journal PloS Genetics , ...
(Date:4/17/2014)... issue of Experimental Biology and Medicine ... Gaskins and Paul Kenis in the Institute of ... University of Illinois Urbana-Champaign describe their recent work ... a variety of cell functions including energy metabolism, ... roles in regulating normal cellular behavior, redox status ...
(Date:4/17/2014)... Bonheur Children,s Hospital Pediatrician-in-Chief Jon McCullers, MD, was ... April issue of Nature Reviews Microbiology , ... Dr. McCullers, a world-renowned infectious disease specialist, and ... University of Tennessee Health Science Center, analyzed the ... 1957 and 1968 pandemics, as well as more ...
(Date:4/17/2014)... estimated that as many as 10 million older Americans ... loneliness and isolation. , However, new research a ... older Americans for six years found that Internet ... depression by more than 30 percent. , "That,s a ... University professor of telecommunication, information studies and media who ...
Breaking Medicine News(10 mins):Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Internet use can help ward off depression among elderly 2
... , BETHEL, Conn., Dec. 4 MedClean Technologies, Inc. (OTC Bulletin ... stock purchase agreement with Socius Capital Group, LLC, a Delaware limited ... LLC. Pursuant to the Purchase Agreement, MedClean will receive up to ... up to 750 shares of its Series C Preferred Stock, in ...
... , UNION, N.J., Dec. 4 ... its specialty anatomic pathology services with the launch of ... company,s expansion from a regional laboratory to a leading ... full range of specialties including gastroenterology, urology and now ...
... , OKLAHOMA CITY, Dec. 4 PD-Rx Pharmaceuticals, Inc. (Pink Sheets: ... September 30, 2009, a 24% decrease over the same period last ... $133,681 and $80,402, respectively, each a 70% decrease over the same ... pharmacy sector sales. This trend is expected to continue throughout ...
... SEATTLE, Dec. 4 The National Cancer Institute has awarded a ... become the nation,s sole operator of its Cancer Information Service Contact ... Hutchinson Center - nearly tripling the size of its current CIS ... scheduled for March 15, 2010. The Seattle CIS center will remain ...
... School of Medicine (BUSM) researchers at the Slone Epidemiology Center ... have a reduced incidence of uterine leiomyomata (fibroids). This report, ... current issue of the American Journal of Epidemiology . ... are two to three times more common among black women ...
... ... support Joint Commission initiative to establish standards for language access in healthcare organizations. ... ... information, drug data solutions, and patient education materials for healthcare institutions, understands the ...
Cached Medicine News:Health News:MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million 2Health News:MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million 3Health News:PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services 2Health News:PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services 3Health News:PD-Rx Pharmaceuticals, Inc. Reports 1st Quarter Earnings 2Health News:Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service 2Health News:Researchers find increased dairy intake reduces risk of uterine fibroids in black women 2Health News:Lexi-Comp Focused on Improving Patient Communication in Healthcare Institutions Treating Diverse Patient Populations 2Health News:Lexi-Comp Focused on Improving Patient Communication in Healthcare Institutions Treating Diverse Patient Populations 3
The Fathom Guidewire combines a nitinol hypotube distal segment with advanced microfabrication technology, creating a design that revolutionizes access of the most tortuous vasculature....
... (hepatitis C virus) is a Microparticle Enzyme ... anti-HCV IgG to HCV recombinant proteins in ... EDTA, sodium heparin, lithium heparin, sodium citrate ... with other laboratory results and clinical information, ...
... MasterControl architecture is the power behind ... provides all the essential building blocks ... management system to boost operational efficiency, ... with regulatory and quality standards. Click ...
... systems are automated, easy to operate and ... outside environment by flexible snap-seal pockets which ... viral contamination of the water. Offered in ... can also accommodate bags of various sizes. ...
Medicine Products: